Incomplete biomarker response in mucopolysaccharidosis type I after successful hematopoietic cell transplantation

Biomarker response after HCT is incomplete, which may reflect residual disease activity. Novel therapeutic strategies should aim for full metabolic correction to minimize clinical manifestations.